CSIMarket


Five Prime Therapeutics Inc   (FPRX)
Other Ticker:  
 


 

Five Prime Therapeutics Inc

FPRX's Financial Statements and Analysis



Five Prime Therapeutics Inc narrowed IV. Quarter net loss per share of $-0.51 compare to net loss per share of $-0.89 recorded in the same quarter a year ago and improved compare to net loss per share of $-0.74 realized in previous quarter.


IV. Quarter
Earnings Per Share Revenues
$ -0.51 $  -1 Mill
$+0.38     $-4M    



Five Prime Therapeutics Inc 's Revenue fell by -122.06 % in IV. Quarter (Dec 31 2020) year on year, to $-1 million and declined by sequentially.


Five Prime Therapeutics Inc is Expected to report next financial results on March 21, 2022.

More on FPRX's Income Statement



Five Prime Therapeutics Inc 's in IV. Quarter recorded net loss of $-21 million, an improvement compare to net loss of $-31 million in IV. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-26.42 million realized in previous quarter.

More on FPRX's Growth

FPRX's Cash flow In IV. Quarter company's net cash flow was $33 million, capital expenditures grew by -93.94%, to $-0 millions compare to same quarter a year ago and rose by -20.00% from III. Quarter (Sep 30 2020).

More on FPRX's Cash flow Statement


Five Prime Therapeutics Inc does not pay out common stock dividend.

In trailing twelve-month period Five Prime Therapeutics Inc payed $ -1.57 cash per share, on a free-cash flow basis .

Book value grew by 140.43 % sequentially to $6.45 per share.
Tangible Book value grew to $ 6.45 per share from $ 2.68.

Company issued 5.61 million shares or 15.78 % in IV. Quarter.


More on FPRX's Dividends

 Market Capitalization (Millions) 1,563
 Shares Outstanding (Millions) 41
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -84
 Cash Flow (TTM) (Millions $) 14
 Capital Exp. (TTM) (Millions $) -0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Five Prime Therapeutics Inc does not pay out common stock dividend.

In trailing twelve-month period Five Prime Therapeutics Inc payed $ -1.57 cash per share, on a free-cash flow basis .

Book value grew by 140.43 % sequentially to $6.45 per share.
Tangible Book value grew to $ 6.45 per share from $ 2.68.

Company issued 5.61 million shares or 15.78 % in IV. Quarter.


More on FPRX's Balance Sheets

 Market Capitalization (Millions) 1,563
 Shares Outstanding (Millions) 41
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -84
 Cash Flow (TTM) (Millions $) 14
 Capital Exp. (TTM) (Millions $) -0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -


   



Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BGNE's Profile

Stock Price

BGNE's Financials

Business Description

Fundamentals

Charts & Quotes

BGNE's News

Suppliers

BGNE's Competitors

Customers & Markets

Economic Indicators

BGNE's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071